The Study
Changes in frailty, intensive blood pressure treatment, and risks of adverse clinical outcomes: a post hoc analysis of the SPRINT trial
This study looked at how people's health got worse or better over a year and saw that those who got frailer were more likely to have heart problems or die. But it didn't make people frailer or healthier — it just watched what happened. So we can say frailty changes are linked to health outcomes, but we can't say they cause them.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
This study looked at older adults with high blood pressure and checked if their frailty (weakness and health decline) got better or worse over a year, and how that affected their heart health and survival.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 567 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — even if someone gets frailer, lowering blood pressure still helps prevent heart problems and death, but it also increases the chance of dangerous side effects like kidney injury or falls.
- 2If frailty got worse, risk of death went up 103%.
- 3If frailty got better, risk of death dropped 52%.
- 4Intensive blood pressure control (target <120) cut heart attacks and deaths by about half, but raised risks of kidney injury and fainting by 22%, no matter if frailty changed or not.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
BMC Medicine
Year
2025
Authors
Xiaoyun Zhang, Xi Meng, Siyu Wang, Qing Lin, Yueyue Wang, Yu Xiang, Kan Wang, Xuan Zhao, Mian Li, Tiange Wang, Zhiyun Zhao, Jieli Lu, Min Xu, Jie Zheng, Yufang Bi, Yu Xu
Related Content
Claims (6)
For frail individuals, aiming for a systolic blood pressure of 120 mm Hg does not improve health outcomes and can lead to adverse effects.
In older adults with high blood pressure and high heart disease risk, worsening frailty over 12 months is linked to a 70% higher rate of heart disease, a 103% higher rate of death from any cause, and a 47% higher rate of serious health events compared to those who stay physically strong.
Older adults with high blood pressure and high heart disease risk who become physically stronger over a year have a 52% lower chance of dying from any cause than those who remain physically weak.
In older adults with high blood pressure and high heart disease risk, lowering systolic blood pressure to below 120 mmHg reduces the chance of heart disease and death, regardless of whether their physical frailty improves, worsens, or stays the same over one year.
In older adults with high blood pressure and high heart disease risk, aggressively lowering blood pressure leads to a 22% higher rate of serious side effects such as kidney injury, fainting, and electrolyte imbalances compared to standard blood pressure treatment, no matter how frail the person is.
Among older adults with high blood pressure and high heart disease risk, about 8.7% become frail and 8.4% recover from frailty over 12 months, showing that frailty can change in either direction over time.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.